CT-01

· Captor Therapeutics S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CT-01, covering 2025-05-29 to 2025-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma [Phase 1]

See pricing